This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
S Akbarian , HS Huang (2006). Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders. Brain Research Reviews 52, 293–304.
MS Ansorge , M Zhou , A Lira , R Hen , (2004). Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science 306, 879–881.
CL Beasley , ZJ Zhang , I Patten , GP Reynolds (2002). Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins. Biological Psychiatry 52, 708–715.
M Cahir , I Costello , DJ King , GP Reynolds (2005). Chronic haloperidol or clozapine treatment does not alter parvalbumin immunoreactivity in the rat frontal cortex or hippocampus. Neuroscience Letters 373, 57–60.
D Cotter , S Landau , C Beasley , R Stevenson , (2002). The density and spatial distribution of GABAergic neurons, labelled using calcium binding proteins, in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia. Biological Psychiatry 51, 377–386.
D Cotter , D Mackay , S Landau , R Kerwin , (2001). Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Archives of General Psychiatry 58, 545–553.
J DeFelipe (1997). Types of neurons, synaptic connections and chemical characteristics of cells immunoreactive for calbindin-D28K, parvalbumin and calretinin in the neocortex. Journal of Chemical Neuroanatomy 14, 1–19.
E Engin , J Stellbrink , D Treit , CT Dickson (2008). Anxiolytic and antidepressant effects of intracerebroventricularly administered somatostatin: behavioral and neurophysiological evidence. Neuroscience 157, 666–676.
L Erraji-BenChekroun , MD Underwood , V Arango , HC Galfalvy , (2005). Molecular aging in human prefrontal cortex is selective and continuous throughout adult life. Biological Psychiatry 57, 549–558.
PL Gabbott , SJ Bacon (1996). Local circuit neurons in the medial prefrontal cortex (areas 24a,b,c, 25 and 32) in the monkey: I. Cell morphology and morphometrics. Journal of Comparative Neurology 364, 567–608.
LA Glantz , MC Austin , DA Lewis (2000). Normal cellular levels of synaptophysin mRNA expression in the prefrontal cortex of subjects with schizophrenia. Biological Psychiatry 48, 389–397.
C Glorioso , M Sabatini , T Unger , T Hashimoto , (2006). Specificity and timing of neocortical transcriptome changes in response to BDNF gene ablation during embryogenesis or adulthood. Molecular Psychiatry 11, 633–648.
MC Gonzalez-Albo , GN Elston , J DeFelipe (2001). The human temporal cortex: characterization of neurons expressing nitric oxide synthase, neuropeptides and calcium-binding proteins, and their glutamate receptor subunit profiles. Cerebral Cortex 11, 1170–1181.
A Guidotti , J Auta , JM Davis , V Giorgi-Gerevini , (2000). Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Archivees of General Psychiatry 57, 1061–1069.
T Hashimoto , HH Bazmi , K Mirnics , Q Wu , (2008). Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia. American Journal of Psychiatry 165, 479–489.
T Hashimoto , SE Bergen , QL Nguyen , B Xu , (2005). Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia. Journal of Neuroscience 25, 372–383.
M Hayashi , A Yamashita , K Shimizu (1997). Somatostatin and brain-derived neurotrophic factor mRNA expression in the primate brain: decreased levels of mRNAs during aging. Brain Research 749, 283–289.
TL Hayes , JL Cameron , JD Fernstrom , DA Lewis (1991). A comparative analysis of the distribution of prosomatostatin-derived peptides in human and monkey neocortex. Journal of Comparative Neurology 303, 584–599.
S Imbeaud , E Graudens , V Boulanger , X Barlet , (2005). Towards standardization of RNA quality assessment using user-independent classifiers of microcapillary electrophoresis traces. Nucleic Acids Research 33, 1–12.
TA Klempan , A Sequeira , L Canetti , A Lalovic , (2009). Altered expression of genes involved in ATP biosynthesis and GABAergic neurotransmission in the ventral prefrontal cortex of suicides with and without major depression. Molecular Psychiatry 14, 175–189.
MA Kling , DR Rubinow , AR Doran , A Roy , (1993). Cerebrospinal fluid immunoreactive somatostatin concentrations in patients with Cushing's disease and major depression: relationship to indices of corticotropin-releasing hormone and cortisol secretion. Neuroendocrinology 57, 79–88.
C Konradi , M Eaton , ML MacDonald , J Walsh , (2004). Molecular evidence for mitochondrial dysfunction in bipolar disorder. Archivers of General Psychiatry 61, 300–308.
AJ Levinson , PB Fitzgerald , G Favalli , DM Blumberger , (2010). Evidence of cortical inhibitory deficits in major depressive disorder. Biological Psychiatry 67, 458–464.
DA Lewis , G Gonzalez-Burgos (2008). Neuroplasticity of neocortical circuits in schizophrenia. Neuropsychopharmacology 33, 141–165.
DA Lewis , B Moghaddam (2006). Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterations. Archives of Neurology 63, 1372–1376.
JE Lisman , JT Coyle , RW Green , DC Javitt , (2008). Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends in Neuroscience 31, 234–242.
D Maciag , J Hughes , G O'Dwyer , Y Pride , (2010). Reduced density of calbindin immunoreactive GABAergic neurons in the occipital cortex in major depression: relevance to neuroimaging studies. Biological Psychiatry 67, 465–470.
N Mellios , HS Huang , SP Baker , M Galdzicka , (2009). Molecular determinants of dysregulated GABAergic gene expression in the prefrontal cortex of subjects with schizophrenia. Biological Psychiatry 65, 1006–1014.
HM Morris , T Hashimoto , DA Lewis (2008). Alterations in somatostatin mRNA expression in the dorsolateral prefrontal cortex of subjects with schizophrenia or schizoaffective disorder. Cerebral Cortex 18, 1575–1587.
EJ Nestler , M Barrot , RJ DiLeone , AJ Eisch , (2002). Neurobiology of depression. Neuron 34, 13–25.
D Ongur , WC Drevets , JL Price (1998). Glial reduction in the subgenual prefrontal cortex in mood disorders. Proceedings of the National Academy of Sciences USA 95, 13290–13295.
E Pallis , A Vasilaki , D Fehlmann , A Kastellakis , (2009). Antidepressants influence somatostatin levels and receptor pharmacology in brain. Neuropsychopharmacology 34, 952–963.
H Pantazopoulos , N Lange , RJ Baldessarini , S Berretta (2007). Parvalbumin neurons in the entorhinal cortex of subjects diagnosed with bipolar disorder or schizophrenia. Biological Psychiatry 61, 640–652.
JB Potash (2006). Carving chaos: genetics and the classification of mood and psychotic syndromes. Harvard Review of Psychiatry 14, 47–63.
G Rajkowska , JJ Miguel-Hidalgo , J Wei , G Dilley , (1999). Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biological Psychiatry 45, 1085–1098.
G Rajkowska , G O'Dwyer , Z Teleki , CA Stockmeier , (2007). GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression. Neuropsychopharmacology 32, 471–482.
DR Rubinow , CL Davis , RM Post (1988). Somatostatin in neuropsychiatric disorders. Progress in Neuropsychopharmacological and Biological Psychiatry 12(Suppl.), S137–S155.
DR Rubinow , PW Gold , RM Post , JC Ballenger , (1983). CSF somatostatin in affective illness. Archives of General Psychiatry 40, 409–412.
G Sanacora , R Gueorguieva , CN Epperson , YT Wu , (2004). Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. Archives of General Psychiatry 61, 705–713.
G Sanacora , GF Mason , DL Rothman , KL Behar , (1999). Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Archives of General Psychiatry 56, 1043–1047.
G Sanacora , GF Mason , DL Rothman , F Hyder , (2003). Increased cortical GABA concentrations in depressed patients receiving ECT. American Journal of Psychiatry 160, 577–579.
G Sanacora , GF Mason , DL Rothman , JH Krystal (2002). Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors. American Journal of Psychiatry 159, 663–665.
SG Schwab , DB Wildenauer (2000). Chromosome 22 workshop report. American Journal of Medical Genetics 88, 276–278.
A Sequeira , T Klempan , L Canetti , J Ffrench-Mullen , (2007). Patterns of gene expression in the limbic system of suicides with and without major depression. Molecular Psychiatry 12, 640–655.
A Sequeira , F Mamdani , C Ernst , MP Vawter , (2009). Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression. PLoS ONE 4, e6585.
E Sibille , DA Lewis (2006). SERT-ainly involved in depression, but when? American Journal of Psychiatry 163, 8–11.
A Surget , Y Wang , S Leman , Y Ibarguen-Vargas , (2009). Corticolimbic transcriptome changes are state-dependent and region-specific in a rodent model of depression and of antidepressant reversal. Neuropsychopharmacology 34, 1363–1380.
GW Valentine , G Sanacora (2009). Targeting glial physiology and glutamate cycling in the treatment of depression. Biochemical Pharmacology 78, 431–439.
J Vandesompele , K De Preter , F Pattyn , B Poppe , (2002). Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biology 3, 34.1–34.11.
J Vela , A Gutierrez , J Vitorica , D Ruano (2003). Rat hippocampal GABAergic molecular markers are differentially affected by ageing. Journal of Neurochemistry 85, 368–377.
DW Volk , MC Austin , JN Pierri , AR Sampson , (2000). Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Archives of General Psychiatry 57, 237–245.
G Weckbecker , I Lewis , R Albert , HA Schmid , (2003). Opportunities in somatostatin research: biological, chemical and therapeutic aspects. Nature Reviews Drug Discovery 2, 999–1017.
CS Weickert , TM Hyde , BK Lipska , MM Herman , (2003). Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia. Mol Psychiatry 8, 592–610.
MC Whitlock (2005). Combining probability from independent tests: the weighted Z-method is superior to Fisher's approach. Journal of Evolutionary Biology 18, 1368–1373.
TU Woo , AM Kim , E Viscidi (2008). Disease-specific alterations in glutamatergic neurotransmission on inhibitory interneurons in the prefrontal cortex in schizophrenia. Brain Research 1218, 267–277.